Fertility and Sterility, 43(4), 514-519, 1985
Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974
Author affiliations
- Mayo Clinic ROR
Abstract
Comparison of a cohort of 988 offspring exposed in utero to exogenous progestins with a matched cohort of unexposed offspring did not result in detection of an association of congenital anomalies with exposure. The conclusions are based primarily on outcomes of pregnancy with exposure to progesterone and 17 alpha-hydroxyprogesterone caproate, and may not apply to androgenic progestins. Offspring exposed to combinations of progestins and estrogens were excluded from this study and may have a different distribution of anomalies.
Topics
Cite this article
Resseguie, L. J., Hick, J. F., Bruen, J. A., Noller, K. L., O'Fallon, W. M., & Kurland, L. T. (1985). Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974. *Fertility and sterility*, *43*(4), 514-519. https://doi.org/10.1016/s0015-0282(16)48490-6
Resseguie LJ, Hick JF, Bruen JA, Noller KL, O'Fallon WM, Kurland LT. Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974. Fertil Steril. 1985;43(4):514-519. doi:10.1016/s0015-0282(16)48490-6
Resseguie, L. J., et al. "Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974." *Fertility and sterility*, vol. 43, no. 4, 1985, pp. 514-519.
Keywords
17 alpha-Hydroxyprogesterone Caproate, Abnormalities, Drug-Induced/epidemiology, Ethisterone/adverse Effects, Female, Fetal Death/epidemiology, Humans, Hydroxyprogesterones/adverse Effects, Infant, Newborn, Male, Maternal-Fetal Exchange, Medroxyprogesterone/adverse Effects, Minnesota, Norethindrone/adverse Effects, Pregnancy, Prenatal Exposure Delayed Effects, Progesterone/adverse Effects, Progestins/adverse Effects, Hydroxyprogesterones, Progestins, 17 alpha-Hydroxyprogesterone Caproate, Progesterone, Medroxyprogesterone, Ethisterone, Norethindrone